Pharma & Biotech
BioNTech’s Insider Sale Doesn’t Deter Wall Street as Oncology Pipeline Takes Center Stage
The German biotech has clawed back more than 22 percent from its March nadir of €72.50, closing Friday at €88.75....
Eli Lilly’s Foundayo Stumbles Out of the Gate, Putting Pressure on Upcoming Earnings
Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750....
ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn
ImmunityBio is posting its strongest-ever quarterly sales, yet the stock is heading in the opposite direction. The biotech group generated...
Ocugen’s Analyst Consensus Is Unanimously Bullish — But the Charts Tell a Different Story
On paper, Ocugen has everything a small-cap biotech investor could want: seven buy ratings, zero holds or sells, and a...
BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds
The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Payer Puzzle Remains Unsolved
Novo Nordisk closed the week with a 6.4% bounce to €35.09, its best single-day showing in months, after unveiling positive...
Bayer’s High-Stakes Summer: A $7.25 Billion Settlement and a Pivotal Supreme Court Hearing
Bayer is entering a defining period for its legal and financial future. The German life sciences group has secured preliminary...
Gerresheimer’s Accounting Crisis Deepens as BaFin Widens Probe
The stock has clawed back 46 percent from its February nadir, but the underlying picture at Gerresheimer remains fraught with...
BioNTech’s Cancer Pipeline Steals the Show as COVID Vaccine Woes Mount
The narrative around BioNTech is undergoing a quiet but decisive shift. While the Mainz-based biotech’s legacy COVID-19 vaccine business sputters,...
Bayer’s Cash Flow Squeeze: Legal Bills Weigh Heavily as Supreme Court Date Nears
Bayer shareholders endured a rough session on Friday as the stock shed nearly 3% to close at €38.87, despite management's...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
